Bureau of Occupational Licenses

1109 Main Street, Suite 220

Boise, ID 83702-5642 


 Minutes of 8/10/2009



BOARD MEMBERS PRESENT:  Shannon Gaertner-Ewing, D.C. - Chair

                                                             Geffery D. Anderson, D.C.

                                                             Glady Schroeder

                                                             Larry D. Nelson, D.C.







BUREAU STAFF:                           Tana Cory, Bureau Chief

                                                            Dawn Hall, Administrative Support Manager

                                                            Lori Peel, Investigative Unit Supervisor

                                                            Roger Hales, Administrative Attorney


OTHERS PRESENT:                     Dr. Joseph Betz

                                                            Dr. Jon Gray

                                                            Dr. Dennis Harper


Meeting was called to order at 12:35 PM MDT by Shannon Gaertner-Ewing, D.C..





The response letter from the Idaho Association of Chiropractic Physicians (IACP) regarding proposed laws and rules was reviewed.  Three issues were discussed.


1) The Blue Cross statement for qualified Chiropractic Assistants was discussed.  The Board felt this was a reimbursement issue and it would be better for the association to carry the proposed changes. 


2) A law change for injectables was discussed.  Dr. Gaertner-Ewing stated that a survey was sent out regarding injectables and the Board received 240 responses.  She had contacted the Board of Pharmacy and it was felt that the best approach would be to define, “what is a practitioner” and that a formulary committee would be the best approach to legend drugs.  Education with no chemicals and no pharmacology would be a problem as they would be unable to identify safety issues.  She reminded the board members and audience and  that the Board of Medicine had concerns with legendary drugs, not with prescriptions.  The Food and Drug Administration changed the definition for legend drugs in 1996.  Vitamin B-12 injectables are classed a legend drug.  IACP will support changes with the formulary council language.


3) A proposed rule regarding changes to ethics was discussed.  Dr. Gartner-Ewing provided a history of the ethics committee.  Dr. Gray stated that they were in favor of a code of ethics, that they were willing to help with the legislation, but they have a pretty full agenda.  The association was under the impression that a couple of their members and a couple of the board members would sit down and go over the code of ethics to get comfortable with them prior to submission and that the final product would have more input from the Association.  Dr. Harper joined the meeting via telephone at 1:45.  Dr. Gartner-Ewing and Dr. Nelson will meet with two representatives from the IACP and other committee members to review the proposed code of ethics.  Dr. Harper requested that he see the history of the resources the committee used in the final draft of the proposed rules. 


A meeting between two members of the board, two members of the association and the ethics committee will be held on Tuesday, August 18, 2009.




Motion was made by Dr. Anderson to adjourn at 2:08 p.m.  Seconded by Dr. Nelson, carried.


_________________________________      _________________________________

Shannon Gaertner-Ewing, D.C., Chair              Geffery D. Anderson, D.C.

_________________________________      _________________________________

Glady Schroeder                                              Larry D. Nelson, D.C.

_________________________________      _________________________________

Robert W. Haug, D.C.                                     Tana Cory, Bureau Chief